News and Media

Latest News Release
11/11/2024

Acquisition of a majority stake in GI Alliance, the country's leading gastroenterology management services organization, to accelerate Cardinal Health's multi-specialty growth strategy Acquisition...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Cardinal Health to Webcast Discussion of Second-Quarter Results for Fiscal Year 2021 on February 5
01/04/2021

DUBLIN, Ohio, Jan. 4, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2021 on February 5 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.

To access the webcast and corresponding slide presentation, go to the Investor Relations page at ir.cardinalhealth.com. No access code is required.  Presentation slides and a webcast replay will be available until February 4, 2022.

Upcoming investor event
Mike Kaufmann, chief executive officer, will present at the 39th Annual J.P. Morgan Healthcare Conference at 9:10 a.m. Eastern, on Monday, Jan. 11, 2021. The presentation will be followed by a Q&A session with Mike Kaufmann and Jason Hollar, chief financial officer. To access more details and to listen to a live webcast of this event, please visit the Investor Relations page at ir.cardinalhealth.com.

About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With 50 years in business, operations in 44 countries and approximately 48,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.

Media: 
Sarah Shew
(614) 553-3401
Sarah.Shew@cardinalhealth.com    

Investors:
Kevin Moran
(614) 757-7942
Kevin.Moran@cardinalhealth.com

SOURCE Cardinal Health

More Company News
12/20/2024

Cardinal Health poised to become the first company to offer cGMP-compliant material at commercial scale by year end DUBLIN, Ohio, Dec. 20, 2024 – Cardinal Health (NYSE: CAH) today announced the...

12/19/2024

Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2025 on January 30, prior to the opening of trading on the New York Stock Exchange. The company...

12/03/2024

ION accelerates development of Navista, integrating more than 100 providers at more than 50 community-based sites across 10 states into oncology practice alliance. DUBLIN, Ohio, Dec. 3, 2024 –...

11/20/2024

Next generation of the Kendall™ SCD Series delivers an all-in-one solution for deep vein thrombosis and pulmonary embolism prevention DUBLIN, Ohio, Nov. 20, 2024 /PRNewswire/ -- Cardinal Health...

View all company news »